RXRX
Recursion Pharmaceuticals, Inc.Company with tickers: RXRX
CIK
1601830
CUSIP
75629V104
Shares Outstanding
524,677,865
13F Activity (30d)
190 filings
186 filers
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2021-04-21 | 2021-04-20 | |
| 10-Q | 2021-05-12 | 2021-03-31 | |
| 8-K | 2021-05-12 | — | |
| 8-K | 2021-07-13 | — | |
| 10-Q | 2021-08-13 | 2021-06-30 | |
| 8-K | 2021-08-13 | — | |
| 8-K | 2021-09-09 | — | |
| 8-K | 2021-10-07 | — | |
| 8-K | 2021-11-10 | — | |
| 10-Q | 2021-11-10 | 2021-09-30 | |
| 8-K | 2021-12-06 | 2021-12-02 | |
| 8-K | 2021-12-07 | 2021-12-05 | |
| 8-K | 2022-01-10 | — | |
| 8-K | 2022-03-03 | — | |
| 8-K | 2022-03-18 | — | |
| 8-K | 2022-03-23 | — | |
| 10-K | 2022-03-23 | 2021-12-31 | |
| 8-K | 2022-04-11 | — | |
| 8-K | 2022-05-10 | — | |
| 10-Q | 2022-05-10 | 2022-03-31 | |
| 8-K | 2022-06-09 | 2022-06-07 | |
| 8-K | 2022-06-16 | 2022-06-14 | |
| 8-K | 2022-06-21 | 2022-06-20 | |
| 10-Q | 2022-08-09 | 2022-06-30 | |
| 8-K | 2022-08-09 | — | |
| 8-K | 2022-09-13 | — | |
| 8-K | 2022-10-25 | 2022-10-24 | |
| 8-K | 2022-11-08 | — | |
| 10-Q | 2022-11-08 | 2022-09-30 | |
| 8-K | 2023-01-10 | — | |
| 8-K | 2023-01-13 | — | |
| 8-K | 2023-01-25 | — | |
| 8-K | 2023-02-27 | — | |
| 10-K | 2023-02-27 | 2022-12-31 | |
| 8-K | 2023-03-10 | — | |
| 10-Q | 2023-05-08 | 2023-03-31 | |
| 8-K | 2023-05-08 | — | |
| 8-K | 2023-05-17 | 2023-05-16 | |
| 8-K | 2023-05-25 | — | |
| 8-K | 2023-06-09 | — | |
| 8-K | 2023-06-13 | — | |
| 8-K | 2023-06-20 | 2023-06-16 | |
| 8-K | 2023-07-12 | 2023-07-11 | |
| 8-K | 2023-08-08 | — | |
| 10-Q | 2023-08-08 | 2023-06-30 | |
| 8-K/A | 2023-08-11 | 2023-06-16 | |
| 8-K | 2023-09-05 | — | |
| 8-K | 2023-10-02 | 2023-09-28 | |
| 8-K | 2023-11-09 | — | |
| 10-Q | 2023-11-09 | 2023-09-30 |
Showing 1–50 of 105 filings